Form 8-K Guardant Health, Inc. For: Feb 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Bernstein SocGen Group Reiterates Outperform Rating on Guardant Health (GH)
February 10, 2025 7:37 AM ESTBernstein SocGen Group analyst Eve Burstein reiterated an Outperform rating and $45.00 price target on Guardant Health (NASDAQ: GH)
The analyst comments "Guardant Health reported this morning that it has reached an agreement for a convertible note exchange. As a reminder, Guardant had $1.15B of convertible notes outstanding with maturity in 2027. The transaction is structured as follows: - $659.3M of outstanding convertible notes (at 0% interest rate with... More
